A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies ; volume:13 ; number:1 ; day:14 ; month:1 ; year:2024 ; pages:173-187 ; date:1.2024
Infectious diseases and therapy ; 13, Heft 1 (14.1.2024), 173-187, 1.2024

Creator
Moullan, Norman
Asiago, Josephat
Stecco, Kathryn
Hadi, Salah
Albizem, Moetaz
Tieu, Holly
Hock, Björn
Fenwick, Craig
Lin, Kai
Lengsfeld, Thomas
Poffenbarger, Lauren
Liu, David
Trono, Didier
Pantaleo, Giuseppe
Venkayya, Rajeev
Bhuyan, Prakash
Contributor
SpringerLink (Online service)

DOI
10.1007/s40121-023-00908-9
URN
urn:nbn:de:101:1-2024041012163173804269
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Moullan, Norman
  • Asiago, Josephat
  • Stecco, Kathryn
  • Hadi, Salah
  • Albizem, Moetaz
  • Tieu, Holly
  • Hock, Björn
  • Fenwick, Craig
  • Lin, Kai
  • Lengsfeld, Thomas
  • Poffenbarger, Lauren
  • Liu, David
  • Trono, Didier
  • Pantaleo, Giuseppe
  • Venkayya, Rajeev
  • Bhuyan, Prakash
  • SpringerLink (Online service)

Other Objects (12)